|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Cardiac and neurologic complications in malignant hypertension due to oral |
| Bortolotto LA; Silva HB; Pileggi F |
| BLOOD PRESSURE. 1994 Sep;3(5):319-21. |
| Although an association between oral contraceptives (OCs) and arterial hypertension has been well-documented, |
| most studies have found only mild or moderate hypertension with reversal to normal levels 3 months after OC |
| discontinuation. This paper presents two cases in which young women developed severe left ventricular hypertrophy |
| and renal failure due to OC-induced malignization of hypertension. The first patient, a 23-year-old, was admitted to |
| the hospital with a 3-day history of headache, mental confusion, and aggressiveness. 6 months before presentation, |
| severe arterial hypertension had been diagnosed. At that time, she was advised to discontinue OCs (30 mcg of |
| ethinyl estradiol and 150 mcg of levonorgestrel), which she had been taking for a year; she did not comply with this |
| directive. The second patient, 21 years old, was admitted with accelerating hypertension. She had initiated OC use |
| (30 mg of ethinyl estradiol and 150 mcg of levonorgestrel) 6 months earlier. 3 months after starting OC use, she |
| developed headache and fatigue. Both women had a hemorrhagic cerebral accident as a complication of malignant |
| hypertension. All neurologic, renal, and cardiovascular complications were reversible after OC discontinuation. OC- |
| related malignant hypertension can be averted through effective control of blood pressure in OC users. |
| (PubHealth.info Document ID: CONT2T 3544-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Cardiac and neurologic complications in malignant |
| hypertension due to oral contraceptive use.", is(are) Bortolotto LA; Silva HB; Pileggi F. The source of this article is |
| "BLOOD PRESSURE. 1994 Sep;3(5):319-21.". This article was published in 1994 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 3544-06. All rights reserved with PubHealth.info) PIN: 8544 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |